Taizhou Dachen Pharmaceutical Co Ltd is a reputable manufacturer in the pharmaceutical industry, established in 2017. The company was designed and built to meet GMP (Good Manufacturing Practice) guidelines, specialising in the research, development, and production of Active Pharmaceutical Ingredients (APIs) and intermediates. With an impressive gross annual output of approximately 400 million yuan, Taizhou Dachen Pharmaceutical has positioned itself as a National High-Tech Enterprise, catering predominantly to markets in Europe, Southeast Asia, and South America.

Services include:
– Regulatory Services
– APIs (Active Pharmaceutical Ingredients)

Taizhou Dachen Pharmaceutical Co Ltd continues to excel in providing high-quality products and services to the pharmaceutical industry. For more information, visit dachenpharm.com.